Page last updated: 2024-11-04

sulfacetamide and Lupus Erythematosus, Systemic

sulfacetamide has been researched along with Lupus Erythematosus, Systemic in 2 studies

Sulfacetamide: An anti-bacterial agent that is used topically to treat skin infections and orally for urinary tract infections.
sulfacetamide : A sulfonamide that is sulfanilamide acylated on the sulfonamide nitrogen.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mackie, BS1
Mackie, LE1
Adams, JD1

Other Studies

2 other studies available for sulfacetamide and Lupus Erythematosus, Systemic

ArticleYear
Systemic lupus erythematosus--dermatomyositis induced by sulphacetamide eye drops.
    The Australasian journal of dermatology, 1979, Volume: 20, Issue:1

    Topics: Adult; Dermatomyositis; Drug Hypersensitivity; Female; Humans; Lupus Erythematosus, Systemic; Ophtha

1979
Drug induced lupus erythematosus--a case report.
    The Australasian journal of dermatology, 1978, Volume: 19, Issue:1

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Sulfacetamide

1978